Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioTech Africa is a South African biotechnology company focused on recombinant protein production and bioprocessing for in vitro diagnostics and research applications. The company designs and manufactures highly purified recombinant proteins used by diagnostic kit manufacturers and research institutions, particularly in infectious disease testing. Its product portfolio includes proteins for HIV, SARS-CoV-2, syphilis, hepatitis C, typhoid, dengue, and Zika, and it also offers custom protein services such as gene design, expression, purification, refolding, structural biology analysis, and scale-up. BioTech Africa positions itself as an ISO 13485-certified supplier serving both local and international customers. The business appears to be more of a life-science tools and diagnostics-enabling company than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioTech Africa.